[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Avisi Technologies Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100609922","safety-and-effectiveness-of-the-visiplate-aqueous-shunt-in-patients-with-refractory-open-angle-glaucoma-100609922",false,"NCT07220876","Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma","A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma","Inclusion Criteria:\n\n* Open angle, pseudoexfoliative or pigmentary glaucoma\n* IOP at preoperative visit of ≥ 20mmHg and ≤ 40mmHg\n* Visual field mean deviation score of -3dB or worse\n* Area of healthy, free and mobile conjunctiva in the target quadrant\n* Shaffer angle grade ≥ 2 in the target quadrant\n\nExclusion Criteria:\n\n* Angle closure glaucoma\n* Congenital, neovascular or other secondary glaucomas\n* Previous intraocular surgery, with the exception of uncomplicated cataract surgery\n* Previous glaucoma shunt\u002Fvalve in the target quadrant\n* Clinically significant inflammation or infection in the study eye within 30 days prior to the operative visit\n* History of corneal surgery, corneal opacities or corneal disease\n* Retinal or optic nerve disorders, either degenerative or evolutive, that are not associated with the existing glaucoma condition","ALL","45 Years",{"count":19,"type":20},165,"ESTIMATED","INTERVENTIONAL",[23],"NA","A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial",[26],"Open Angle Glaucoma (OAG)",[28],"Glaucoma","RECRUITING","2025-12-08",{"date":32,"type":33},"2025-12-15","ACTUAL",{"date":35,"type":33},"2025-11-07",{"date":37,"type":20},"2027-10",{"name":39,"class":40},"Avisi Technologies Inc.","INDUSTRY",12,""]